9,203
Total Claims
$1.2M
Drug Cost
669
Beneficiaries
$1,763
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
+25%
Cost per patient vs peers
$1,763 vs $1,411 avg
+40%
Brand preference vs peers
14.9% vs 10.6% avg
Brand vs Generic
85% generic
Brand: 1,356 claims · $972K
Generic: 7,772 claims · $182K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 112 | $163K |
| Apixaban | 133 | $127K |
| Empagliflozin | 81 | $111K |
| Dulaglutide | 79 | $83K |
| Insulin Aspart | 57 | $59K |
| Insulin Glargine,hum.Rec.Anlog | 68 | $55K |
| Liraglutide | 23 | $42K |
| Fluticasone/Vilanterol | 34 | $28K |
| Linagliptin | 24 | $25K |
| Rivaroxaban | 20 | $24K |
| Fluticasone/Umeclidin/Vilanter | 17 | $20K |
| Atorvastatin Calcium | 933 | $17K |
| Umeclidinium Brm/Vilanterol Tr | 18 | $17K |
| Albuterol Sulfate | 221 | $14K |
| Fluticasone Propionate | 22 | $13K |
Prescribing Profile
Patient Profile
71
Avg Age
56%
Female
1.42
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data